Endo Inc. (NDOI)
OTCMKTS
· Delayed Price · Currency is USD
21.34
0.00 (0.00%)
May 23, 2025, 9:30 AM EDT
Endo Inc. Revenue
Endo Inc. had revenue of $392.83M in the quarter ending March 31, 2025, a decrease of -6.36%. This brings the company's revenue in the last twelve months to $1.73B, down -9.52% year-over-year. In the year 2024, Endo Inc. had annual revenue of $1.76B, down -12.50%.
Revenue (ttm)
1.73B
Revenue Growth
-9.52%
P/S Ratio
0.95
Revenue / Employee
556.31K
Employees
3,116
Market Cap
1.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.76B | -251.38M | -12.50% |
Dec 31, 2023 | 2.01B | -307.36M | -13.25% |
Dec 31, 2022 | 2.32B | -674.33M | -22.53% |
Dec 31, 2021 | 2.99B | 90.13M | 3.10% |
Dec 31, 2020 | 2.90B | -11.29M | -0.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
American Oncology Network | 1.76B |
Endo Inc. News
- 11 days ago - ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc. - NDOI - Business Wire
- 12 days ago - Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration - PRNewsWire
- 14 days ago - Mallinckrodt and Endo Announce Significant Progress in Proposed Merger - PRNewsWire
- 20 days ago - Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance - PRNewsWire
- 4 weeks ago - Endo's New Spatial Computing Injection Simulator for Peyronie's Disease Creates Immersive Learning Environment for Urology Specialists - PRNewsWire
- 7 weeks ago - Endo to Report First Quarter 2025 Financial Results on May 7, 2025 - PRNewsWire
- 2 months ago - Endo Launches Spatial Computing Simulator to Create a Fully Immersive Learning Environment for Hand Specialists - PRNewsWire
- 2 months ago - Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress - PRNewsWire